Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source

Source document· March 18, 2026

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs

View original at finance.yahoo.com

FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs Expanded label for once-yearly parasiticide treatment for dogs now includes Haemaphysalis longicornis (Asian longhorned tic…

Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

BRAVECTO QUANTUM delivers the longest-lasting protection available in a single dose, now covering an even broader range of clinically important tick species
60% confidence
BRAVECTO QUANTUM is the longest-lasting flea and tick protection available for dogs in the United States
60% confidence
Fleas and ticks are not only active in the spring and summer months and are a year-round risk
60% confidence
Fleas are the most common external parasite found on pets
60% confidence
The flea lifecycle can last as long as 12 weeks, and monthly treatments may leave gaps in protection
60% confidence
For more than a decade, BRAVECTO has set the benchmark for extended-duration flea and tick protection
60% confidence
Safety was demonstrated when BRAVECTO QUANTUM was dosed at 5 times the recommended dose every 4 months for a total of 6 doses
60% confidence
Asian longhorned and Gulf Coast ticks continue to expand geographically and present risks to canine health
60% confidence